Cybin Inc. (OTCMKTS:CLXPF - Get Free Report)'s share price shot up 2% during trading on Friday . The stock traded as high as $7.26 and last traded at $7.06. 189,192 shares traded hands during trading, a decline of 66% from the average session volume of 551,962 shares. The stock had previously closed at $6.92.
Cybin Trading Down 1.3 %
The stock has a fifty day moving average of $7.05 and a two-hundred day moving average of $8.97. The company has a market capitalization of $998.58 million and a PE ratio of -28.00.
Cybin Company Profile
(
Get Free Report)
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
Read More
Before you consider Cybin, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cybin wasn't on the list.
While Cybin currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
